These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 28230926

  • 1. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
    Ouyang DQ, Liang LZ, Ke ZF, Zheng GS, Weng DS, Yang WF, Su YX, Liao GQ.
    Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
    [Abstract] [Full Text] [Related]

  • 2. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors.
    Yamada Y, Kohashi K, Fushimi F, Takahashi Y, Setsu N, Endo M, Yamamoto H, Tokunaga S, Iwamoto Y, Oda Y.
    Cancer; 2014 Mar 15; 120(6):864-76. PubMed ID: 24353015
    [Abstract] [Full Text] [Related]

  • 3. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R, Mitani Y, Diao L, Guijarro I, Wang J, Zweidler-McKay P, Bell D, William WN, Glisson BS, Wick MJ, Kapoun AM, Patnaik A, Eckhardt G, Munster P, Faoro L, Dupont J, Lee JJ, Futreal A, El-Naggar AK, Heymach JV.
    J Clin Oncol; 2017 Jan 20; 35(3):352-360. PubMed ID: 27870570
    [Abstract] [Full Text] [Related]

  • 4. The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation.
    Ettl T, Schwarz-Furlan S, Haubner F, Müller S, Zenk J, Gosau M, Reichert TE, Zeitler K.
    Oral Oncol; 2012 Sep 20; 48(9):822-30. PubMed ID: 22445095
    [Abstract] [Full Text] [Related]

  • 5. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.
    BJU Int; 2012 Dec 20; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
    Šteiner P, Andreasen S, Grossmann P, Hauer L, Vaněček T, Miesbauerová M, Santana T, Kiss K, Slouka D, Skálová A.
    Virchows Arch; 2018 Oct 20; 473(4):471-480. PubMed ID: 29619555
    [Abstract] [Full Text] [Related]

  • 7. Temsirolimus, the mTOR inhibitor, induces autophagy in adenoid cystic carcinoma: in vitro and in vivo.
    Liu W, Huang S, Chen Z, Wang H, Wu H, Zhang D.
    Pathol Res Pract; 2014 Nov 20; 210(11):764-9. PubMed ID: 24767255
    [Abstract] [Full Text] [Related]

  • 8. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
    Schwarz S, Müller M, Ettl T, Stockmann P, Zenk J, Agaimy A.
    Int J Clin Exp Pathol; 2011 Apr 20; 4(4):336-48. PubMed ID: 21577319
    [Abstract] [Full Text] [Related]

  • 9. High expression of the autophagy gene Beclin-1 is associated with favorable prognosis for salivary gland adenoid cystic carcinoma.
    Liang LZ, Ma B, Liang YJ, Liu HC, Zheng GS, Zhang TH, Chu M, Xu PP, Su YX, Liao GQ.
    J Oral Pathol Med; 2012 Sep 20; 41(8):621-9. PubMed ID: 22712799
    [Abstract] [Full Text] [Related]

  • 10. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG.
    Oncotarget; 2015 Sep 22; 6(28):25506-19. PubMed ID: 26325518
    [Abstract] [Full Text] [Related]

  • 11. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S, Ito Y, Fujii K, Saida K, Takino H, Masaki A, Murase T, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Ijichi K, Murakami S, Inagaki H.
    Histopathology; 2017 Aug 22; 71(2):305-315. PubMed ID: 28370175
    [Abstract] [Full Text] [Related]

  • 12. High expression of H3K9me3 is a strong predictor of poor survival in patients with salivary adenoid cystic carcinoma.
    Xia R, Zhou R, Tian Z, Zhang C, Wang L, Hu Y, Han J, Li J.
    Arch Pathol Lab Med; 2013 Dec 22; 137(12):1761-9. PubMed ID: 24283856
    [Abstract] [Full Text] [Related]

  • 13. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
    Hämetoja H, Hirvonen K, Hagström J, Leivo I, Saarilahti K, Apajalahti S, Haglund C, Mäkitie A, Bäck L.
    Virchows Arch; 2017 Dec 22; 471(6):785-792. PubMed ID: 28600602
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study.
    Andreasen S, Tan Q, Agander TK, Hansen TVO, Steiner P, Bjørndal K, Høgdall E, Larsen SR, Erentaite D, Olsen CH, Ulhøi BP, Heegaard S, Wessel I, Homøe P.
    Virchows Arch; 2018 Sep 22; 473(3):329-340. PubMed ID: 30069755
    [Abstract] [Full Text] [Related]

  • 15. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
    Bell D, Ferrarotto R, Fox MD, Roberts D, Hanna EY, Weber RS, El-Naggar AK.
    Cancer Biol Ther; 2015 Sep 22; 16(6):834-8. PubMed ID: 25923130
    [Abstract] [Full Text] [Related]

  • 16. RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.
    Zhang CY, Zhao YX, Xia RH, Han J, Wang BS, Tian Z, Wang LZ, Hu YH, Li J.
    PLoS One; 2014 Sep 22; 9(10):e110159. PubMed ID: 25302792
    [Abstract] [Full Text] [Related]

  • 17. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
    Bazarsad S, Kim JY, Zhang X, Kim KY, Lee DY, Ryu MH, Kim J.
    Yonsei Med J; 2018 Aug 22; 59(6):717-726. PubMed ID: 29978608
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
    Hirvonen K, Bäck L, Haglund C, Leivo I, Jouhi L, Mäkitie AA, Hagström J.
    Tumour Biol; 2016 Aug 22; 37(8):10959-64. PubMed ID: 26888781
    [Abstract] [Full Text] [Related]

  • 19. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
    Rettig EM, Tan M, Ling S, Yonescu R, Bishop JA, Fakhry C, Ha PK.
    Laryngoscope; 2015 Sep 22; 125(9):E292-9. PubMed ID: 25963073
    [Abstract] [Full Text] [Related]

  • 20. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K, Murase T, Beppu S, Saida K, Takino H, Masaki A, Ijichi K, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Inagaki H.
    Histopathology; 2017 Nov 22; 71(5):823-834. PubMed ID: 28594149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.